Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC: World’s leading Event Organizer
About Prague|Prague Conferences
Prague is the capital and greater city of the Czech Republic. It is the 15th biggest city in the European Union. It is also the archival capital of Bohemia. Positioned in the north-west of the country on the Vltava River, the city is central to about 1.26 million people, while its larger urban zone is predicted to have a population of nearly 2 million. The city has a temperate climate, with mild summers and chilly winters. Prague has the lowest unemployment rate in the European amalgam. Prague has been a political, cultural, and economic median of central Europe with waxing and waning fortunes during its 1,100-year existence. Prague was endowed during the Romanesque and flourishing by the Gothic, Renaissance and Baroque generation, Prague was not only the capital of the Czech state, but also the lounge of two Holy Roman Emperors and thus also the capital of the Holy Roman federation. It was an important city to the Habsburg Monarchy and its Austro-Hungarian Empire and later World War I became the capital of Czechoslovakia.
Prague City Highlightes|Prague Conferences
Twenty-three universities operate in the Czech Republic. Charles University, founded in 1348, is one of the oldest and best-known institutions of higher learning in Europe. The Czech Academy of Sciences and a large technical university also reside in Prague.
Universities in Prague|Prague Conferences
Charles University in Prague
Czech Technical University in Prague
University of Economics, Prague
Metropolitan University Prague
University of New York in Prague
Czech University of Life Sciences Prague
Faculty of Social Sciences, Charles University in Prague
Academy of Arts, Architecture and Design in Prague
University of Chemistry and Technology, Prague
Academy of Performing Arts in Prague
Academy of Fine Arts, Prague
University of Finance and Administration
First Faculty of Medicine, Charles University in Prague
Banking Institute / College of Banking
Architectural Institute In Prague (ARCHIP)
University of International and Public Relations Prague
University of Northern Virginia in Prague
Palacký University, Olomouc
Brno University of Technology
Technical University of Ostrava
Associations in Prague|PragueConferences
Association of Chemical Industry of the Czech Republic
Czech Chemical Society
The Czech Society for Biochemistry and Molecular Biology
Czech Society of Clinical Biochemistry
Association of Manufacturers and Suppliers of Medical Devices
Czech Medical Association
The Association of Private Cardiologists in the Czech Republic
Czech medical society for acupuncture of the Czech medical association of J.E. Purkyne
Czech Society Of Sports Medicine
Association of Innovative Pharmaceutical Industry
Czech Diabetes Society
Czech society of cardiology
Czech society for oncology
Society of Occupational Medicine of the Czech Medical Association of J. E. Purkyně
European federation of Nurses association
The European Biomass Association
European Federation of Psychologists' Associations
European Surgical Association
European Wind Energy association
European Association of Pharma Biotechnology
European Biopharmaceutical Enterprises
European Federation of Pharmaceutical Industries and Associations
European Chemical Industry
European Dairy Association
European Smoking Tobacco Association
European Society of Cardiology
Pharma and Biotech Companies and Industries in Prague | Prague Conferences
AstraZeneca, Czech Republic
Pfizer, Czech Republic
Bristol-Myers Squibb, Czech Republic
DuPont Pharmaceuticals Company
Dow Chemical Company
Conferences in Prague|Prague Conferences
18th International Conference on Environmental Chemistry and Chemical Technologies, October 6 - 7, 2016, Prague, Czech Republic
22nd international congress of chemical and process engineering (CHISA) August 27-31, 2016, Prague, Czech Republic
International Conference on the Coordination and Organometallic Chemistry of Germanium, Tin and Lead (ICCOC-GTL 2016), 28 August 2016 - 2 September 2016, Pardubice, Czech Republic.
Solid state chemistry conference, September 18-23,2016, Prague, Czech Republic
8th year of the Central European Conference, “Chemistry towards Biology” 28th August – 1st September 2016, Brno, Czech Republic
7th French-Czech "Vltava" Chemistry Meeting, September 5-6,2016, Czech Republic
12th international student’s conference ‘Modern Analytical chemistry’ September 22-23, 2016, Prague, Czech Republic
ISER-71st International Conference on Chemical and Environmental Science (ICCES), October 26-27,2016, Prague, Czech Republic
2nd Prague International Academic Conference on Business & Economics Conference, 4-7 September 2016, Prague, Czech Republic
6th International Conference on Trends in Agricultural Engineering, 7-9 September, 2016, Prague, Czech Republic
13th European Congress of Clinical Pharmacology and Therapeutics – EACPT 24-27 June, 2016, Prague, Czech Republic
European Conference on Mental Health, September 14-16,2016, Prague, Czech Republic
Congress of the Czech Orthodontic Society, September 22-24,2016 Prague, Czech Republic
16th International Nutrition & Diagnostics Conference, October 3 - 6, 2016, Prague, Czech Republic
Experimental fluid mechanics 2016, November 15-18,2016, Czech Republic
4th International Conference on Food Security and Nutrition, March 13-15, 2017, Prague, Czech Republic
13th European Congress of Clinical Pharmacology and Therapeutics, June 24-27,2017, Prague, Czech Republic
4th International Conference on Chemical and Biological Sciences, March 13-15, 2017, Prague, Czech Republic
77th International Conference on Environment and Natural Science, September 23-24,2016, Prague, Czech Republic
1st International Conference on Electrical & Electronics Engineering, November 23-25,2016, Rome Italy
95th International Conference on Chemical and Biochemical Engineering, December 12-13,2016, Rome, Italy
World Veterinary Vaccine Congress, October 10-12,2016, Barcelona, Spain
Applied Nanotechnology and Nano science International Conference, November 9-11,2016, Barcelona, Spain
2nd International Conference on Nano biotechnology, April 2-6,2017, Barcelona, Spain
35th Meeting of the European Society for Paediatric Infectious Diseases, May 23-27,2016 Madrid, Spain
Optics and Measurement International Conference October 11-14,2016, Liberec, Czech Republic
Frontiers of Quantum and Mesoscopic Thermodynamics, July 9-15, 2017, Prague, Czech Republic
Process Scale-Up in the Pharmaceutical Industry, September 29-30,2016, Prague, Czech Republic
123rd International Conferences on Metallurgy Technology and Materials (ICMTM), January 21-22,2017, Prague, Czech Republic
131st International Conference on Food and Agricultural Engineering (ICFAE), 21-22,2017, Prague, Czech Republic
6th Computer Science On-line Conference, April 26-29,2017, webinar, Czech Republic
18th International Conference on Clinical Pharmacy, Hemotherapy and Drug Development,
October 6 - 7, 2016, Prague, Czech Republic
4th International Congress on Translational Medicine (EUSTM-2016), October 17-20, 2016, Praha, Czech Republic
The 26th World Congress on Ultrasound in Obstetrics and Gynaecology, September 25-28,2016, Rome Italy
The 24th United European Gastroenterology Week, October 15-19,2016, Vienna, Austria
The European Cancer Congress, January 27-30,2016, Amsterdam, Netherlands
The 15th St. Gallen International Breast Cancer Conference, March 15-18,2016, Vienna, Austria
The 25th European Congress of Psychiatry, April 1-4,2017, Florence Italy
ECCMID 2017 - The 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25,2017, Vienna, Austria
EAS 2017 - The 85th Congress of the European Atherosclerosis Society, April 23-26,2017, Prague, Czech Republic
The 19th European Congress of Endocrinology, May 20-23,2017, Lisbon, Portugal
World Congress of Pharmacy and Pharmaceutical Sciences, May 21-24,2017, Stockholm, Sweden
The 18th European Federation of National Association of Orthopaedics and Traumatology Congress, 31 May - 02 June 2017, Vienna, Austria
The European Meeting on Hypertension and Cardiovascular Protection, June 16-19,2017, Milano, Italy
The 3rd Congress of the European Academy of Neurology, June 24-27,2017, Amsterdam, Netherlands
The 32nd International Congress on Epilepsy, September 2-6,2017, Barcelona, Spain
Tourist Attractions in Prague| Prague Conferences
Prague astronomical clock
St. Vitus Cathedral
Old Town Square
Church of Our Lady before Týn
Old Jewish Cemetery, Prague
Petřín Lookout Tower
Prague National Theatre
Church of Our Lady Victorious
Prague Jewish Museum
National Museum, Prague
Old New Synagogue
Total health spending assumed for 7.5% of GDP in the Czech Republic in 2012. In the Czech Republic, 84% of health spending was subsidized by public sources in 2012. Health funding in the Czech Republic has grown very slowly in recent years.
Pharmaceutical consumption per capita (US$ PPP) in 2000 was 230 and in 2012 was 439.
Annual growth of pharmaceutical spending (in real terms) since 2010, in Czech Republic
Beckman Research Institute of the City of Hope funds $150,000 a two year allotment to implement the End-of-Life Nursing Education Consortium, a national education enterprise to improve palliative care, in the Czech Republic.
International Society of Nurses in Cancer Care (ISNCC) funds $150,000 two year allotment to guide a collaborative project that accommodates a series of capacity-building Tobacco Cessation Leadership Workshops to educate nurses on overture in tobacco restriction, cancer prevention, treatment and care.
National Centre of Nursing and Other Health Professions funds $110,146 two year grant to guide a project to educate community nurses in cancer prevention and to strongly engage nurses in the education and encouragement of healthy lifestyle for cancer patients.
The meadow of allergy and clinical immunology is one of the quickly growing areas among medical science in Czech Republic.
Market for autoimmune medication reached at $34 billion in 2010, it is expected to reach at $38.9 billion by 2011 and it will farther grow to $55 billion by 2016. Market value for autoimmune disorder diagnostics for 2013 was valued at $11.9 billion. This is expected to ambit about $12.1 billion in 2014 and $13.1 billion in 2019. Global autoimmune infection diagnostics market is expected to reach USD 14.17 billion by 2020.
The investigation showed that 127 million Europeans experience from brain disorders. It is extensively recognized that funds for brain research are important for the evolution of new therapies and to increase knowledge about brain disorders.
The neuroscience market was prized over USD 24 billion in 2013. It is predicted to attain USD 30.8 billion by 2020.
Total fundings on brain research in Europe in 2005 amounted to approximately €4.1 billion, of which €855 million came from the public zone (21% of total funding). Government funding constituted 78% of total public funding while 22% came from charitable authorities. The European pharmaceutical industry funded approximately €3.3 billion on brain research per year.
Public spendings for brain research varied between European countries, ranging from €60 000 in Malta to €312 million in the UK. Ireland had the maximum level of public spending per inhabitant (€6.73), followed by the UK (€5.2) and Hungary (€2.7). The least level was found in Latvia (€0.14 per inhabitant). Hungary, the Netherlands, Norway, Sweden and France also had per capita donates above the European average, which was estimated at €1.2. Industry funding of brain research (€3.25 billion) is larger than industry funding of cancer research (€2.5 billion).
Funding’s For Brain Research
Cancer investigation in Europe received about €1.5 billion of public funding (50% government and 50% charities) and around €2.5 billion of industry funding.
There were 1.75 million afterlife from cancer in Europe in 2012. In the European Union, the predicted numbers of new cases of cancer were roughly 1.4 million in males and 1.2 million in females. Cancer Drugs Market estimate to reach $111.9 billion by 2020.
In 2007, the countries with the maximal percentage of female engineering workers were already communist Eastern European countries such as Latvia (30.6 per cent), Bulgaria (29.6 per cent), Croatia (28.6 per cent) and Lithuania (27.5 per cent).
The UK has a 17% global market share in aerospace industry earnings. The UK’s electronics field generates approximately £29 billion a year in revenues. Global engineering R&D market to reach $1.4 trillion by 2020. Overall funding on ER&D enlarged 12 percent from $980 billion in 2008 to $1.1 trillion in 2009 and is conventional to expand to $1.4 trillion by 2020. Mechanical engineering is culpable for 9.5% of all the production in EU manufacturing industries. The European mechanical engineering area is expected to grow at an annual average rate of 3.8% over the next 10 years.
Expected development of mechanical engineering output
In 2011 the market for coronary stent equipment’s reached $7.1 billion. And it is expected that total market amount will reach $10.6 billion in 2016. The market for cardiac medical devices is habitual to reach about $67.5 billion in 2019. The market for cardiac equipment growth had risen from $49.4 billion in 2013 to $52 billion in 2014. The market for heart-lung and pump apparatus and grew from $2.6 billion in 2012 to $3.4 billion in 2014.
The European interventional cardiology equipment market was valued at $3.9 billion in 2013 and is expected to reach $6.1 billion by 2018, at a CAGR of 9% during the estimated period.
Market Trends in Europe Interventional Radiology and Cardiology" finds that the market earned roughly $336.7 million in 2012 and estimates this to reach $352.6 million in 2016. The European cardiology PACS market was priced at $118.1 million in 2013, and is expected to grow at a CAGR of 7.2% from 2014 to 2019.
In Europe, an average of 10.4% of (GDP) is funded on healthcare. Expenditure on medical technology per capita in Europe is at around €195.
Market Size of chemistry is approximately $ €543 billion a year. With a workforce of 1.2 million and sales of €527 billion (2013). Generally, Europe has been a leader in chemicals manufacturing. The European chemical industry holds a better position. When counting both EU and non-EU countries, total sales for the region were €673 billion in 2011. Chemicals sales in 2012, prized at €51.7 billion, nearly half of which was attributed to four EU countries – Austria, Sweden, Czech Republic and Finland. Total EU chemicals business was worth €558 billion in 2012. EU chemicals sales in 2012 were 34.5 per cent greater compared with 2002. During the period from 2002 to 2012, EU chemicals sales enlarged on average by 3 per cent per annum. During the 11-year period from 2001 to 2012, the chemical company in the European Union had an regular production growth rate of 0.6 per cent, a rate marginally higher than the 0.4 per cent for all of the production industry. Growth in EU chemicals manufacturing in 2010 was spectacular, embracing 10.6 per cent year on year. The overall economic recovery in Europe was feeble, however, with anaemic production growth in 2011 – 1.9 per cent in volume terms, followed by a 2.3 per cent year-on-year contraction in 2012.
Total funding’s on health in least-developed countries is roughly $17 a person a year (of which about $6 is from the Government budget). Influenza vaccine market: projected at $2.9 billion in 2011 to $3.8 billion by 2018. Global market forecasted to rise to $100 by 2025; More than 120 new products in the growth pipeline and 60 are of importance for emerging countries. The global injections market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a growing rate of 11.8% from 2014 to 2019.
Gulhane Military Medical Academy Training Hospital, Turkey
Benha University, Egypt
Energy Research Institute (ERI) United Kingdom
Department of Chemistry, University of Samarra, Iraq
Title:Synthesis and characterization of 2-((4R,4aR,5aS,6S)-1,3-dioxo3m3a,4,4a,5,5a6,6a-octahydro-4,6- ethenocyclopropa[f]isoindol-2(1H)-yl)-N-(substituted phenyl) acetamides anticipated to have HIV- 1 activity
Lewisham and Greenwich NHS Trust, UK
Leipzig University, Germany
University Cadi Ayyad-Marrakesh, Morocco
Green Life Hospital Ltd., Bangladesh
Pomeranian Medical University in Szczecin, Poland
Departement Of Pharmacy STIKES Mandala Waluya , Indonesia
Inonu University, Turkey
Marmara University, Turkey
BIA Separations, Slovenia
Mater Dei Hospital, Malta
Forest Research Institute, Chile
University of Geneva, Switzerland
Pal College of nursing and medical sciences,India
University of Juba College of Applied &Industrial Sciences, South Sudan
Hebrew University, Israel
Almaarefa Colleges for Science & Technology, Saudi Arabia
Institute for Medical Research and Occupational Health, Croatia
All India Institute Of Medical Sciences, India
Riga Stradins University, Latvia
New Hanover Regional Medical Center, USA
Reims University School of Medicine, France
Havana University, Cuba
University of Coimbra, Portugal
University of Coimbra, Portugal
Massachusetts General Hospital, USA
King Abdullah Specialized children Hospital, Saudi Arabia
South Carolina State University, USA
University of Malaya, Malaysia
University of Venda, South Africa
Pion Inc., USA
Giresun University, Turkey
University of Debrecen, Hungary
Inland Technology Incorporated, USA
Meditrina Hospitals, India
University of Porto, Portugal
University of Porto, Portugal
Mehmet Akif Ersoy University Faculty of Health Sciences , Turkey
University of Strathclyde, UK
Technische Universität Ilmenau, Germany
Universidade de Santiago de Compostela, Spain
Ospedale della Murgia, Italy
National Institute of Technology, India